User profiles for "author:Ronen Arbel"

Ronen Arbel

Sapir College
Verified email at sapir.ac.il
Cited by 1523

[HTML][HTML] BNT162b2 vaccine booster and mortality due to Covid-19

R Arbel, A Hammerman, R Sergienko… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of the B. 1.617. 2 (delta) variant of severe acute respiratory
syndrome coronavirus 2 and the reduced effectiveness over time of the BNT162b2 vaccine …

[HTML][HTML] Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge

R Arbel, Y Wolff Sagy, M Hoshen, E Battat… - … England Journal of …, 2022 - Mass Medical Soc
Background The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-
risk, unvaccinated patients infected with the B. 1.617. 2 (delta) variant of severe acute …

[HTML][HTML] Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

R Arbel, R Sergienko, M Friger, A Peretz… - Nature medicine, 2022 - nature.com
The rapid emergence of the B. 1.1. 529 (Omicron) variant of SARS-CoV-2 led to a global
resurgence of coronavirus disease 2019 (COVID-19). Israeli authorities approved a fourth …

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

R Arbel, A Peretz, R Sergienko, M Friger… - The Lancet Infectious …, 2023 - thelancet.com
Background In late 2022, the SARS-CoV-2 omicron (B. 1.1. 529) BA. 5 sublineage
accounted for most of the sequenced viral genomes worldwide. Bivalent mRNA vaccines …

[HTML][HTML] Effectiveness of the BNT162b2 vaccine after recovery from Covid-19

A Hammerman, R Sergienko, M Friger… - … England Journal of …, 2022 - Mass Medical Soc
Background The risk of infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) decreases substantially among patients who have recovered from …

Effectiveness and safety of off-label dose-reduced direct oral anticoagulants in atrial fibrillation

R Arbel, R Sergienko, A Hammerman… - The American Journal of …, 2019 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) reduce the risk of stroke and
systemic embolism in patients with nonvalvular atrial fibrillation but may result in serious …

Prediction models for heart failure in the community: A systematic review and meta‐analysis

R Nadarajah, T Younsi, E Romer… - European Journal of …, 2023 - Wiley Online Library
Aims Multivariable prediction models can be used to estimate risk of incident heart failure
(HF) in the general population. A systematic review and meta‐analysis was performed to …

[HTML][HTML] Real-world effectiveness of a single dose of mpox vaccine in males

Y Wolff Sagy, R Zucker, A Hammerman, H Markovits… - Nature Medicine, 2023 - nature.com
The recent global outbreak of the monkeypox (mpox) virus in humans was declared a public
health emergency by the World Health Organization in July 2022. The smallpox and mpox …

Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case …

D Yamin, M Yechezkel, R Arbel… - The Lancet Infectious …, 2023 - thelancet.com
Background COVID-19 continues to be a major health threat, particularly among at-risk
groups, including individuals aged 60 years or older and people with particular medical …

Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis

J Azuri, A Hammerman, E Aboalhasan… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aims Higher doses of the glucagon‐like peptide‐1 agonist semaglutide and, more recently,
tirzepatide, a dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide …